Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes

BACKGROUND: Information about the effectiveness of oral antivirals in preventing short- and long-term COVID-19-related outcomes during the Omicron surge is limited. We sought to determine the effectiveness of nirmatrelvir-ritonavir and molnupiravir for the outpatient treatment of COVID-19. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajema, Kristina L., Berry, Kristin, Streja, Elani, Rajeevan, Nallakkandi, Li, Yuli, Yan, Lei, Cunningham, Francesca, Hynes, Denise M., Rowneki, Mazhgan, Bohnert, Amy, Boyko, Edward J., Iwashyna, Theodore J., Maciejewski, Matthew L., Osborne, Thomas F., Viglianti, Elizabeth M., Aslan, Mihaela, Huang, Grant D., Ioannou, George N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774229/
https://www.ncbi.nlm.nih.gov/pubmed/36561190
http://dx.doi.org/10.1101/2022.12.05.22283134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774229/
https://www.ncbi.nlm.nih.gov/pubmed/36561190
http://dx.doi.org/10.1101/2022.12.05.22283134

Ejemplares similares